Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Trimegah Bangun Persada Tbk. (NCKL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Trimegah Bangun Persada Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 22.7K 24h volume), while Trimegah Bangun Persada Tbk. trades at Rp830 (market cap 52.69T, 3.43M 24h volume). The key difference: Trimegah Bangun Persada Tbk. is far larger — about 171.1× Diagnos Laboratorium Utama Tbk.'s market cap, and Trimegah Bangun Persada Tbk. is more actively traded (3.43M versus 22.7K). Which is the better fit depends on your goals.
| DGNS | NCKL | |
|---|---|---|
Market Cap | 308B | 52.69T |
Volume | 22.7K | 3.43M |
Lot | 227 | 34.3K |
Turnover | 5.17M | 2.87B |
Average Price | 227.59 | 836.71 |
Value | 5.17M | 2.87B |
Indicative Equilibrium Price | 230 | 840 |
Indicative Equilibrium Volume | 110 | 12.21K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Trimegah Bangun Persada Tbk.
PT Trimegah Bangun Persada Tbk. (the Company) was established in Indonesia based on Notarial Deed of Erna Priyono, S.H., No. 03 dated September 6, 2004.
Read more on NCKL →
